Pemra bans 'Jalan' over indecent content

Regulatory authority cited complaints from viewers the reason for the immediate ban


Entertainment Desk September 11, 2020
PHOTO: ARY

In a recent notification, Pakistan Electronic Media Regulatory Authority (PEMRA), on Thursday, banned the ARY Digital’s drama Jalan. The reason behind the ban was cited to be the complaints received to the regulatory authority by the viewers for indecent content. 

In the notice issued by Pemra, it was said that Jalan did not align with the cultural and societal values of the country. The notice went on to add that the Minal Khan, Emaad Irfaani serial went against the ethics and morals of Pakistan. 

The statement further reads that the regulatory body had given repeated warnings to the channel earlier as well to revise the content of the aforementioned show, however, since no changes were made and the warnings fell on deaf ears, the show ha now been banned under Section 27 of the Pemra Ordinance.

Previously, the show irked few with its 'troublesome' script. Jalan stars Minal, Emaad and Areeba Habib in lead roles and revolves around an apparently love triangle, and infidelity. 

Have something to add to the show? Share it in the comments below. 

COMMENTS (4)

Khadija Farhaan | 1 year ago | Reply

Yes its banned but what about Dil Ruba, what about other dramas alike jalan, atleast they could end the drama by something like either the latter nisha becomes mad or die. Anyways I was disappointed to know just as reaching to 32 episode they banned the drama where it could ended easily instead of banning it.

Mahnoor Khan | 1 year ago | Reply

it is a good step by pemra to ban such dramas. but why they haven't ban drama "Dil ruba" where the sanum second husband committed an adultery and the writers and producers have normalize it so much like they haven't done anything wrong............

VIEW MORE COMMENTS
Replying to X

Comments are moderated and generally will be posted if they are on-topic and not abusive.

For more information, please see our Comments FAQ

E-Publications

Most Read